Viewing Study NCT00176605


Ignite Creation Date: 2025-12-25 @ 3:20 AM
Ignite Modification Date: 2026-05-15 @ 7:46 PM
Study NCT ID: NCT00176605
Status: COMPLETED
Last Update Posted: 2014-05-20
First Post: 2005-09-13
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase II Metronomic Dosing, Etoposide, Cyclophosphamide, D0 Prostate Cancer
Sponsor:
Organization: